Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Elephas harnesses latest advances in cancer biology, multimodal microscopy, and artificial intelligence to empower clinical decision-making.
Be Biopharma develops engineered B cell medicines for serious genetic diseases.
HC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Sonoma Biotherapeutics develops engineered regulatory T-cell (Treg) therapies to treat autoimmune and inflammatory diseases.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Soufflé Therapeutics has potent, precise, and safe medicines can be designed and developed for all diseases.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
Metsera is a clinical‐stage biotech firm developing oral & injectable hormone therapies to treat obesity & related metabolic diseases.
908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.
Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.
Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.
Pelage Pharma is a regenerative medicine biotechnology company developing treatments for hair loss.
Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.
Atlas Data Storage is an information technology company focused on data storage solutions.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Salma Health is a concierge neurocognitive clinic that uses neurology and psychiatry techniques to solve various brain conditions.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Syndex Bio is a biotechnology platform offering molecular technologies and AI for the diagnosis and treatment of disease.
ARCH Venture Partners has invested in 236 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
ARCH Venture Partners's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 22 different industry categories.
Among tracked funding rounds, Resilience received $825.0M in a Debt Financing round. ARCH Venture Partners's total known invested capital is $22.6B.
ARCH Venture Partners's average investment size is $122.9M across its portfolio of 236 companies.
Recent ARCH Venture Partners portfolio additions include Faraday Pharmaceuticals, Synchron, Elephas, Be Biopharma, hC Bioscience. These companies were founded in 2020 or later.